Literature DB >> 23210129

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.

Nancy L Keating, A James O'Malley, Stephen J Freedland, Matthew R Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23210129      PMCID： PMC3634556          DOI： 10.1093/jnci/djs376

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  43 in total

1.  Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system?

Authors:  Kaiping Zhang; Li Zhang; Zongyao Hao; Chaozhao Liang
Journal:  World J Urol       Date:  2015-09-30       Impact factor: 4.226

2.  Radiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted".

Authors:  Nicholas G Zaorsky; Mark A Hallman; Marc C Smaldone
Journal:  Ann Transl Med       Date:  2015-10

3.  Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.

Authors:  O Moran; L J V Galietta; O Zegarra-Moran
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

4.  Prognostic factors in Chinese patients with prostate cancer receiving primary androgen deprivation therapy: validation of Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity and diabetes mellitus.

Authors:  Meng-Bo Hu; Tian Yang; Ji-Meng Hu; Wen-Hui Zhu; Hao-Wen Jiang; Qiang Ding
Journal:  Int J Clin Oncol       Date:  2018-01-06       Impact factor: 3.402

5.  [Antihormonal therapy in prostate cancer : Side effects].

Authors:  C H Ohlmann; P Thelen
Journal:  Urologe A       Date:  2017-04       Impact factor: 0.639

6.  Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy.

Authors:  Hideyasu Tsumura; Takefumi Satoh; Hiromichi Ishiyama; Shuhei Hirano; Ken-Ichi Tabata; Shinji Kurosaka; Kazumasa Matsumoto; Tetsuo Fujita; Masashi Kitano; Shiro Baba; Kazushige Hayakawa; Masatsugu Iwamura
Journal:  World J Radiol       Date:  2015-12-28

7.  National survey addressing the information needs of primary care physicians: Side effect management of patients on androgen deprivation therapy.

Authors:  Tony Soeyonggo; Jennifer Locke; Maria Elizabeth Del Giudice; Shabbir Alibhai; Neil Eric Fleshner; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

8.  Population pharmacokinetic-pharmacodynamic modelling of the relationship between testosterone and prostate specific antigen in patients with prostate cancer during treatment with leuprorelin.

Authors:  Nelleke Snelder; Henk-Jan Drenth; Kirsten Riber Bergmann; Nolan David Wood; Mark Hibberd; Graham Scott
Journal:  Br J Clin Pharmacol       Date:  2019-04-03       Impact factor: 4.335

Review 9.  The role of androgens in metabolism, obesity, and diabetes in males and females.

Authors:  Guadalupe Navarro; Camille Allard; Weiwei Xu; Franck Mauvais-Jarvis
Journal:  Obesity (Silver Spring)       Date:  2015-03-06       Impact factor: 5.002

10.  Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male.

Authors:  Guadalupe Navarro; Weiwei Xu; David A Jacobson; Barton Wicksteed; Camille Allard; Guanyi Zhang; Karel De Gendt; Sung Hoon Kim; Hongju Wu; Haitao Zhang; Guido Verhoeven; John A Katzenellenbogen; Franck Mauvais-Jarvis
Journal:  Cell Metab       Date:  2016-04-28       Impact factor: 27.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.